Your browser doesn't support javascript.
loading
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
Cuker, Adam; Bass, Ann D; Nadj, Congor; Agius, Mark A; Steingo, Brian; Selmaj, Krzysztof W; Thoits, Timothy; Guerreiro, Alexandre; Van Wijmeersch, Bart; Ziemssen, Tjalf; Meuth, Sven G; LaGanke, Christopher C; Thangavelu, Karthinathan; Rodriguez, Claudio E; Baker, Darren P; Margolin, David H; Jannsens, Ann.
Afiliação
  • Cuker A; Departments of Medicine and Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Bass AD; Neurology Center of San Antonio, San Antonio, TX, USA.
  • Nadj C; Institute of Neurology, Novi Sad, Serbia.
  • Agius MA; Woodland Clinic, Dignity Health, Woodland, CA, USA.
  • Steingo B; Fort Lauderdale MS Center, Pompano Beach, FL, USA.
  • Selmaj KW; University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
  • Thoits T; College of Human Medicine, MSU Spectrum Health, Grand Rapids, MI, USA.
  • Guerreiro A; Instituto de Doenças Neurológicas do Hospital Mãe de Deus, Porto Alegre, Brazil.
  • Van Wijmeersch B; Rehabilitation and MS Centre Overpelt, BIOMED, University of Hasselt, Hasselt, Belgium.
  • Ziemssen T; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Meuth SG; Department of Neurology, University of Münster, Münster, Germany.
  • LaGanke CC; North Central Neurology Associates, Cullman, AL, USA.
  • Thangavelu K; Sanofi, Cambridge, MA, USA.
  • Rodriguez CE; Sanofi, Cambridge, MA, USA.
  • Baker DP; Current affiliation: Sunovion Pharmaceuticals, Marlborough, MA, USA.
  • Margolin DH; Sanofi, Cambridge, MA, USA.
  • Jannsens A; Sanofi, Cambridge, MA, USA.
Mult Scler ; 26(1): 48-56, 2020 01.
Article em En | MEDLINE | ID: mdl-30785358
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Gestao Bases de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Esclerose Múltipla Recidivante-Remitente / Interferon beta-1a / Alemtuzumab / Fatores Imunológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Gestao Bases de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Esclerose Múltipla Recidivante-Remitente / Interferon beta-1a / Alemtuzumab / Fatores Imunológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos